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Background:Microtubule-associated protein 1B (MAP1B) is a protein that is prominently expressed during early neuronal
development but in adult brain remains in areas with high synaptic plasticity.
Results:MAP1B plays an important role in dendritic spine formation and synaptic maturation.
Conclusion: A novel function for MAP1B in regulating dendritic spine morphology and synaptic function is indicated.
Significance:MAP1B could contribute to adult brain plasticity.
Microtubule-associated protein 1B (MAP1B) is prominently
expressed during early stages of neuronal development, and it
has been implicated in axonal growth and guidance. MAP1B
expression is also found in the adult brain in areas of significant
synaptic plasticity. Here, we demonstrate that MAP1B is pres-
ent in dendritic spines, andwe describe a decrease in the density
ofmature dendritic spines in neurons ofMAP1B-deficientmice
thatwas accompanied by an increase in thenumber of immature
filopodia-like protrusions. Although these neurons exhibited
normal passive membrane properties and action potential fir-
ing, AMPA receptor-mediated synaptic currents were signifi-
cantly diminished.Moreover,weobserved a significant decrease
in Rac1 activity and an increase in RhoA activity in the post-
synaptic densities of adult MAP1B/ mice when compared
with wild type controls. MAP1B/ fractions also exhibited a
decrease in phosphorylated cofilin. Taken together, these
results indicate a new and important role for MAP1B in the
formation andmaturation of dendritic spines, possibly through
the regulation of the actin cytoskeleton. This activity ofMAP1B
could contribute to the regulation of synaptic activity and plas-
ticity in the adult brain.
Microtubules (MTs)4 are non-covalent cytoskeletal poly-
mers composed of - and -tubulin heterodimer subunits that
are assembled into linear protofilaments. These are essential
structures for the maintenance of neuronal morphology and in
developing neurons. MTs are highly dynamic structures that
are involved in neurite extension and the establishment of neu-
ronal polarity (1). By contrast, in differentiated andmature neu-
rons, axonal and dendritic MTs become more stable due to
their interactions with structural MT-associated proteins
(MAPs) (2) such as Tau and MAP2, respectively (3). Thus,
MAPs contribute to neuronal morphology by regulating the
balance between MT stability and plasticity in neuronal pro-
cesses (4). These proteins are differentially expressed during
brain development, displaying a transition from juvenile to
adult isoforms that correlateswith thematuration of the central
nervous system (CNS) and the stabilization of neuronal cir-
cuitry (5, 6).
MAP1B (7) is the first MAP to be expressed strongly in the
nervous system during embryonic development (8). Subse-
quently, its expression is developmentally down-regulated until
it almost disappears from the axon during the formation of
synaptic contacts between neurons in theCNS (9–13). The role
ofMAP1B in axonogenesis has been widely studied (for review,
see Ref. 14). Thus, suppression ofMAP1B with antisense oligo-
nucleotides inhibits laminin enhanced axon growth (15), and
there is a significant delay in axon outgrowth and a reduced rate
of axon elongation in cultured hippocampal pyramidal neurons
fromMAP1B-deficient mice (16, 17).
MAP1B was recently shown to regulate Rac1 activity during
axonal outgrowth through its interaction with Tiam1, a Rac1-
GEF (guanosine nucleotide exchange factor). Accordingly,
MAP1B deficiency results in a decrease in the activity of the
Rho-GTPases Rac1/cdc42 and an increase in RhoA activity
(18). These results are consistent with members of the Rho
family of small GTPases, including RhoA, Rac1, and cdc42, reg-
ulating the cross-talk between actin and MTs in developing
neurons, affecting axon specification, guidance, and elongation
(19, 20).
MAP1B has been described in the post-synaptic compart-
ment (21–23), a scaffolding specialization of the neuronal syn-
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apses at the tip of the dendritic spine. Dendritic spines are
actin-rich membrane protrusions that extend from the den-
dritic shaft with a globular head and thin neck. As a basic func-
tional unit of the excitatory synapse, dendritic spines are critical
for most excitatory nerve transmission in the brain (24). Spines
are dynamic structures that undergo actin-dependent changes
in shape, size, and number, and thus, they represent major sites
of structural synaptic plasticity (25). Rho-GTPases such as Rac1
and RhoA are key players in regulating the dynamics of the
actin cytoskeleton in neuronal spine morphogenesis (26, 27).
Moreover, Tiam1 has also been implicated in NMDA receptor
activity-dependent structural plasticity (28).
Although it is well established that F-actin is the major cyto-
skeletal component of dendritic spines (29), it was previously
thought that MTs were absent from these structures and that
theywere confined to the dendritic shaft inmature neurons (30,
31). However, the transient presence of dynamic MTs in den-
dritic spines of adult neurons was recently confirmed, implicat-
ing MTs in spine formation and plasticity (32–34). The pres-
ence of a MT-binding protein in dendritic spines was also
demonstrated recently, participating in spine morphogenesis
(34).
Although the role ofMAP1B in axonal development has been
studied extensively, little is known of its function in postsynap-
tic compartments and particularly in dendritic spines. Based on
the activity of MAP1B as a scaffold protein (35–37), its interac-
tion with actin filaments (36, 38), and the recently described
role ofMTs in dendritic spine development, we postulated that
MAP1B may be involved in regulating the morphogenesis and
plasticity of postsynaptic elements. As such, we demonstrate
here that MAP1B plays an important role in dendritic spine
formation and synaptic maturation by regulating of actin
cytoskeleton.
EXPERIMENTAL PROCEDURES
Primary Antibodies—The following primary antibodies (Ab)
were used here: mouse anti--tubulin Ab (1:2000; Sigma);
mouse Ab anti--actin (Sigma); goat Ab againstMAP1B (N-19,
1:2000; Santa Cruz Biotechnology); mouse anti-HMW-MAP2
(clone HM-2, 1:5000; Sigma); goat anti-Tau (C-17, 1:1000;
Santa Cruz Biotechnology); mouse Ab against phosphorylated
neurofilament heavy subunit (SMI-34, 1:1000; Sternberger
Monoclonals); rabbit anti-GEF-H1 (1:1000; Abcam); rabbit
anti-Tiam1 (clone C-16, 1:200; Santa Cruz Biotechnology);
anti-cofilinmAb (1:1000; a generous gift of Dr. James Bamburg,
Colorado State University); rabbit anti-phospho-cofilin (Ser-3,
clone 77G2, 1:1000; Cell Signaling); antibodies against Rac1 and
RhoA (1:500; Cytoskeleton, Inc.).
The phosphorylation-independent Tau monoclonal anti-
body 7.51 (39) was kindly provided by Dr. C. M. Wischik. The
monoclonal antibodies Tau-1 and Tau-5 were purchased from
Chemicon International and Calbiochem, respectively.
Cell Culture—Cultures of dissociated hippocampal pyrami-
dal cells from wild type (WT) and MAP1B knock-out (KO)
mouse embryonic brains were prepared as previously described
(40). The hippocampus was removed and digested with papain
andDNase (Worthington Biochemical Corp.). 50,000 cells/cm2
were plated onto 12-mm glass coverslips (precoated with 100
g/ml poly-L-lysine) in wells containing Neurobasal medium
with 10% horse serum. After 3 h the plating medium was
replaced with Neurobasal medium supplemented with 2 mM
L-glutamine, 2mM D-pyruvate, 1%N2-supplement and 2%B27-
supplement (GIBCO), 100 units/ml penicillin, and 100 mg/ml
streptomycin. Hippocampal cells were cultured over a mono-
layer of astrocytes prepared from the cortex of newborn (P0)
Swiss-Webster mice. The cortices were treated with trypsin
andDNase, and the tissue pieces were dissociatedmechanically
and passed through a 70-m mesh filter (BD Falcon) in mini-
mum Eagle’s medium supplemented with 10% horse serum,
0.6% glucose, 0.2 mM glutamine, and antibiotics. 400,000 cells/
well were seeded in 6-well plates and grown for 21 days until a
confluent monolayer of astrocytes was established. All culture
media and supplements were purchased from Invitrogen. Neu-
ronal cultures weremaintained in a humidified 37 °C incubator
with 5% CO2 until 21 days in vitro (DIV).
Immunofluorescence—At 21 DIV, primary cells were fixed
with 4% paraformaldehyde, 4% sucrose for 20 min at 4 °C. The
cells were incubated with phosphate-buffered saline (PBS),
0.1% Triton X-100 for 5 min and then blocked with PBS, 5%
(w/v) bovine serum albumin (BSA) for 1 h. Subsequently, the
cells were incubated with primary antibodies raised against the
proteins indicated and diluted in PBS, 1% BSA. The fluorescent
secondary antibodies (Molecular Probes, Invitrogen) were used
at a dilution 1:400. Phalloidin-TRITC (Sigma) and phalloidin-
FITC (Molecular Probes) were both used at a concentration of
1:200 to label the actin cytoskeleton. Cells were analyzed on a
Zeiss LSM 510 META confocal scanning microscope.
Protein Extracts andWesternBlotting—Protein extractswere
prepared from the hippocampus, corpus callosum (white mat-
ter), or cortex (gray matter) of adult mice in 20 mMHEPES (pH
7.4) containing 0.1 mMNaCl, 10 mMNaF, 1 mMNa3VO4, 5 mM
EDTA, 1mM okadaic acid, and protease inhibitors (2mM phen-
ylmethylsulfonyl fluoride, 10 mg/ml aprotinin, 10 mg/ml leu-
peptin, 10 mg/ml pepstatin). Protein extracts were boiled for 5
min in electrophoresis sample buffer (50mMTris-HCl (pH6.8),
100 mM dithiothreitol, 2% SDS, 0.1% bromphenol blue, 10%
glycerol) and then separated by SDS-PAGE and transferred
onto nitrocellulose membranes (Whatman). The membranes
were blockedwith 5% dried nonfatmilk in PBS and 0.1%Tween
20 and probed for 1 h at room temperature with the primary
antibody in the blocking solution. After threewashes, themem-
brane was incubated with a horseradish peroxidase secondary
antibody (DAKO) followed by several washes in PBS-Tween 20.
Antibody binding was visualized by ECL (PerkinElmer Life Sci-
ences) and quantified by densitometry.
ImageAnalysis andDendritic SpineQuantification—To ana-
lyze the number, length, and head and neck morphology of
dendritic spines, we acquired confocal images of wt and knock-
out neurons at 21 DIV using an oil immersion 63 objective.
Photos were taken at a resolution of 1024  1024 pixels and a
pinhole of 0.60 m.
To perform three-dimensional reconstructions of spine
morphology, Z-stacks of 13 planes were generated, each sepa-
rated by 0.150 m. Images were subsequently deconvoluted
using the Huygens program and reconstructed using the IDL
time Calc program. The classification of dendritic spine type
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was carried out according to the following criteria; 1) mush-
room spines were those with a large head of a diameter greater
than 0.75 m and with a short narrow neck, 2) stubby spines
were those with no obvious constriction between the head and
the shaft, 3) thin spines were those with a small head of a diam-
eter between 0.5–0.7 m and a long narrow neck, and 4) filop-
odia were defined as thin protrusions longer than 1.5 m and
with no distinct head. Spine density and length were quantified
in 3 dendritic branches per neuron (at least 3 independent
experiments, 10 neurons per experiment).
Immunoprecipitation—The hippocampus of an adult mouse
brain was homogenized in 0.7 ml of cold immunoprecipitation
buffer (20 mMTris (pH 7.5), 0.5% Triton X-100, 100mMNaCl),
and the homogenate was then centrifuged for 15 min at 13,500
rpm and 4 °C. The supernatant obtained was considered as the
total cell lysate.
To 400 g of the supernatant, 1 g of an antibody against
MAP1B or a mixture of Tau antibodies (Tau-1, Tau 7.51,
Tau-5) was added in a final volume of 1 ml. As a negative con-
trol, goat ormouse IgG isotype control antibody (forMAP1B or
Tau immunoprecipitation experiments, respectively; Santa
Cruz Biotechnology) was incubated with the extract. The solu-
tion was vortexed and incubated for another 1 h at 4 °C, and 20
l of 50% Protein A-agarose bead solution was then added,
mixed, and incubated with agitation for 30 min at 4 °C. The
beads were recovered by centrifugation for 15 min at 13,500
rpm and 4 °C, and the supernatant was removed. The pellet was
washed twice with the immunoprecipitation buffer and resus-
pended in 30 l of 2 concentrated electrophoresis sample
buffer. The proteins were separated by gel electrophoresis, and
the fractionated proteins then characterized in Western blots.
Synaptosome Purification—The protocol used to purify syn-
aptosome fractions from adult rat brain is based on well estab-
lished methods that have been described previously (41, 42).
The whole adult mouse brain was homogenized at 800 rpm/7
strokes in a Dounce glass homogenizer in 4 vol/g of buffer A
(0.32 mM sucrose, 1 mMMgCl2, 0.5 mM CaCl2, 1 mM NaHCO3,
1 mM dithiothreitol, and protease inhibitors (2 mM phenyl-
methylsulfonyl fluoride, 10mg/ml aprotinin, 10mg/ml leupep-
tin, 10mg/ml pepstatin). After the addition of 10 vol/g of buffer
A, the homogenate was centrifuged for 10 min at 1400  g to
recover the supernatant S1 and the pellet P1. P1 was resus-
pended in 4 vol/g of buffer A, homogenized at 800 rpm/3
strokes, and recentrifuged for 10 min at 700 g. The resulting
supernatant was combined with S1 and centrifuged for 10 min
at 13,800  g. The resulting supernatant (S2) was separated
from the pellet P2 and centrifuged at 100,000  g for 1 h. The
supernatant obtained (S3) constitutes the cytosolic fraction. P3
was resuspended in 24 ml/10 g wet weight of buffer B (0.32 mM
sucrose, 1 mMNaHCO3, 1 mM EGTA, 1 mM dithiothreitol, and
protease inhibitors (2 mM phenylmethylsulfonyl-fluoride, 10
mg/ml aprotinin, 10 mg/ml leupeptin, 10 mg/ml pepstatin))
and homogenized to obtain the crude synaptosome fraction. To
separate the synaptic components, the synaptosome fraction
was diluted 10 in ice-cold 0.1 mM CaCl2. The same volume of
a 2 concentrated solution (40mMTris (pH 6.0) and 2%Triton
X-100) was added. This was incubated for 30 min on ice with
mild agitation and centrifuged for 30 min at 30,000 rpm in a
TL856 rotor. The pellet constituted the synaptic junctions, and
the supernatant contained the extrasynaptic proteins. The pel-
let was washed with 20 mM Tris (pH 6.0) and 1% Triton X-100
and resuspended in 500l of 20mMTris (pH8.0) and 1%Triton
X-100. This solution was then incubated on ice for 30 min with
mild agitation and centrifuged at 30,000 rpm in aTL100.1 rotor.
The resulting pellet was resuspended in 50 l of lysis buffer (50
mM Tris, 150 mM NaCl, 1% Triton X-100, 0.5% deoxycholate
(pH 7.2)), and this last fraction (the postsynaptic density frac-
tion) was analyzed in Rho-GTPase activity assays andWestern
blots. Synaptophysin was used to exclude the presence of pre-
synaptic matrix and postsynaptic density fraction 95 as a
marker of the postsynaptic density fraction.
Assays of Rho-GTPase Activity—The Rac1 activity assay was
performed as described previously (43). Briefly, the synapto-
some fraction from adult mice (2 months of age) was lysed at
4 °C in 50mMTris, 150mMNaCl, 1%TritonX-100, 0.5%deoxy-
cholate (pH 7.2). GTP-bound Rac1 was affinity-purified from
cell lysates at 4 °C using an immobilized GST fusion of the
Rac1-binding domain of murine p21-activated protein kinase
(PAK), which binds Rac1-GTP but not Rac1-GDP. Bound pro-
teins were separated by 12% SDS-PAGE and immunoblotted
with anti-Rac1 antibodies (Rac1 activation assay Biochem kit,
Cytoskeleton, Inc). Pulldown assays and immunoblots for acti-
vated RhoA were performed as described for Rac1 but using an
immobilized GST fusion of the Rho binding domain of the Rho
effector protein, rhotekin. TheRhobinding domainmotif binds
specifically to the GTP-bound form of RhoA. Total RhoA and
RhoA-GTP were detected with mouse anti-RhoA antibodies
(RhoA activation assay Biochem kit, Cytoskeleton, Inc.).
Recordings of Miniature Excitatory Postsynaptic Currents—
Voltage-clamp whole-cell recordings were obtained from 21
DIV hippocampal neurons from MAP1B/ and MAP1B/
mice at 60 mV in the presence of 100 M 2-amino-5-phos-
phonovaleric acid; Sigma) and tetrodotoxin (1 M, Sigma).
Spontaneous events were acquired and analyzed with pClamp
software (Molecular Devices).
Solutions—The recording chamber was perfused with aCSF:
119mMNaCl, 2.5mMKCl, 2.5mMCaCl2, 1.3mMMgCl2, 26mM
NaHCO3, 1 mM NaH2PO4, 11 mM glucose, 0.1 mM picrotoxin
(pH 7.4), gassed with 5% CO2, 5% O2. Patch recording pipettes
(3–6 megaohms) were filled with 115 mM cesium methanesul-
fonate, 20 mM CsCl, 10 mM HEPES, 2.5 mM MgCl2, 4 mM
Na2ATP, 0.4mMNa3GTP, 10mM sodium phosphocreatine, 0.6
mM EGTA (pH 7.25).
Nocodazole Treatment—Hippocampal neurons obtained
fromwild typemice were cultured for 2 weeks and then treated
with nocodazole (Sigma) added for 3 h at a final concentration
of 30g/ml. NIE-115mouse neuroblastoma cells (ATCC)were
cultured in Dulbecco’s modified Eagle’s medium plus 10% fetal
bovine serum, 2 mM L-glutamine, 100 units/ml penicillin, and
100 mg/ml streptomycin at 37 °C in 5% CO2. Cell differentia-
tion was induced by overnight serum deprivation, and NIE-115
cells were treated with nocodazole (10 g/ml) for 20 min. Cell
extracts were prepared in cold immunoprecipitation buffer and
centrifuged for 15min at 13,500 rpm and 4 °C. The supernatant
was considered as the total cell lysate. The immunoprecipita-
tion was performed as described previously.
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Statistical Analysis—All the statistical tests were performed,
and all the graphs were constructed with GraphPad Prism5
software. Statistical analysis was performed using parametric
(Student’s t test) and non-parametric (Mann-Whitney test)
tests depending on normality of the data sets (assessed with the
Shapiro-Wilk test) at a significance level of p  0.05. p values
are indicated in the graphs, and p 0.05 is considered indica-
tive of a statistically significant difference. All data are
expressed as the means S.E.
RESULTS
MAP1B Is Present in Dendritic Compartments of Mature
Neurons—The presence and distribution of MAP1B in adult
brain was analyzed by immunofluorescence in brain slices from
wild typemice. The nature of the cellular extensions was deter-
mined by staining with antibodies against dendritic and axonal
marker proteins, HMW-MAP2 and phosphorylated neurofila-
ment heavy subunit, respectively.MAP1Bwas detected primar-
ily in the dendrites of hippocampal neurons (Fig. 1, A–H). To
confirm these results, we isolated white matter and gray matter
from adult wild type mouse brain and analyzed the presence of
MAP1B in these regions. Although gray matter is enriched in
the somatodendritic compartment, it also contains fractions of
neuropil containing unmyelinated and myelinated axons and
glial cells as well as capillaries. Using neurofilament heavy sub-
units and HMW-MAP2 as axonal and dendritic markers, we
demonstrated that the graymatter fraction did not contain high
levels of axonal material, but rather, it was enriched in somato-
dendritic compartments. In addition, MAP1B is mainly
expressed in neurons and only weakly in glial cells, whereas it is
absent from capillaries (44–47). Thus, MAP1B was concen-
trated in the gray matter, and it was less prevalent in the white
matter, as reported previously (48, 49).
MAP1B Is Present in Some but Not All Dendritic Spines—Dy-
namic MTs and MT-binding proteins have been recently
detected in dendritic spines ofmature neurons (32–34). Hence,
we examined the detailed subcellular distribution ofMAP1B in
mature dendrites. Immunostaining of 21 DIV hippocampal
neurons with antibodies directed against MAP1B (N19) and
HMW-MAP2 (as a dendritic marker) revealed that MAP1B
predominantly localized within the dendritic compartment
(Fig. 2, A–D). However, immunostaining using anti-MAP1B
(N19) and phalloidin (which targets F-actin and was used as a
marker of dendritic spines and filopodia) demonstrated that
MAP1B was occasionally observed in a small fraction of the
dendritic protrusions (arrowhead in Fig. 2, E–G), colocalizing
with F-actin (Fig. 2G). These F-actin-positive structures ful-
filled the morphological and morphometric criteria to be con-
sidered dendritic spines. Immunostaining of MAP1B knock-
out neurons was performed as a negative control (Fig. 2, H–J).
The number of dendritic spines that are positive for MAP1B
staining represents 1%. Interestingly, in the pioneering studies
demonstrating the presence of MTs in dendritic spines, the
percentage of invasion ofMTs in dendritic spines on fixed cells
was estimated to be 1–4% (32–34, 50).
MAP1B Is Important for Proper Spine Formation—After the
detection of MAP1B in some dendritic spines, we investigated
whether decreased expression ofMAP1B could affect dendritic
spine morphogenesis. We previously characterized MAP1B-
deficient mice generated by gene trapping (51). Homozygous
mice die perinatally, whereas heterozygous mice develop with
no evident neurological problems. We, therefore, established
long term cultures of hippocampal neurons derived from
MAP1B homozygous and wild type littermates in the presence
of an astrocyte monolayer. Using this culture model we ana-
lyzed the morphology and number of dendritic protrusions in
the knock-out and wild type neurons. When hippocampal WT
and MAP1B/ neurons were stained at 21 DIV with HMW-
MAP2 (dendritic marker) and phalloidin (dendritic protrusion
marker; Fig. 3, A–D), there were significantly fewer dendritic
protrusions on neurons from MAP1B/ mice than on those
from MAP1B/ mice (Fig. 3E). Moreover, the filopodia-like
protrusions of knock-out neurons were generally longer (2
FIGURE 1. MAP1B is present in adult brain. A–H, shown are representative immunofluorescence images of WT mouse brain slices (30 m thick) from
2-month-old animals. The slices were stained with antibodies against the specific dendritic marker HMW-MAP2 (green, A) and specific axonal marker neuro-
filaments (NF) (green, E) and againstMAP1B (red, B and F) andIII-tubulin (blue, C andG). MAP1B is located in the apical dendrites of CA1 hippocampal neurons
(D–H). Scale bar 20m. I, a Western blot demonstrates the presence of MAP1B in both white and graymatter in the adult mouse, although staining is more
abundant in the graymatter (upper panel). We used HMW-MAP2 as a dendritic marker (bottom panel) and phosphorylated neurofilament heavy subunit as an
axonal marker in the white matter.
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m) than those of the wild type controls (Fig. 3F). Three-di-
mensional reconstructions were performed to classify the dif-
ferent dendritic protrusions observed. Protrusions from con-
trol neurons predominantly exhibited the morphological
characteristics ofmaturemushroom-shaped and stubby spines,
with a large head and no distinguishable neck (Fig. 4, A, C, and
FIGURE 2.MAP1B is detected in a small percentage of dendritic spines. A–D, confocal images are shown of 21 DIV hippocampal WT neurons stained with
antibodies against the specific dendritic marker HMW-MAP2 (green, A), MAP1B (red, B), and III-tubulin (blue, C). HMW-MAP2 labeling reveals the presence of
MAP1B indendrites (D). Scale bar20m. E–J, confocal imagesof 21DIVhippocampal neurons stainedwithphalloidin (green, E) andMAP1B (red, F) are shown.
MAP1B is present in some dendritic spines (arrows), co-localizing with phalloidin in the spine head (G). MAP1B immunostaining of MAP1B knock-out neurons
was performed as a negative control (H–J). Scale bar 10 m.
FIGURE 3.MAP1B is important forproper spine formation.AandB, confocalmicroscopy images showthemorphologyof 21DIVhippocampalMAP1B/ (A) and
MAP1B/ neurons (B) stained with phalloidin (green) and HMW-MAP2 (red). Scale bar 20m. C and D, a magnified image is shown; note that WT neurons have
mature spine-like protrusions with a defined head (C), whereas KO neurons exhibit long and thin filopodia-like protrusions (D). Scale bar 2 m. E, quantitative
analyses indicatethatMAP1B-deficientneuronsexhibita lowerdensityofdendriticprotrusions(*,p0.001,Student’s t test).F,quantitativeanalysesdemonstratethat
the protrusions inMAP1B/ neurons are longer than in control neurons (n 10 neurons from three independent experiments per condition).
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E). In contrast, most protrusions from MAP1B/ neurons
corresponded to immature spines and were classified as filop-
odia, long thin protrusions without a distinguishable head (Fig.
4, B, D, and E). Taken together, these observations are consist-
ent with the spine length measurements described above.
The Absence of MAP1B Decreases Postsynaptic Function—
Electrophysiological studies were performed to determine
whether the decrease in mature dendritic spine number in the
MAP1B knock-out mice affects synaptic function. We first
examined the passive membrane properties of MAP1B/ and
control neurons. Whole-cell recordings using a current-clamp
configuration revealed no significant alterations in membrane
capacitance (related to cell membrane surface), input resist-
ance, or resting membrane potential (related to resting ionic
conductances) in MAP1B/ hippocampal neurons (supple-
mental Fig. 1, A–C). Moreover, we found no differences in the
action potential threshold, amplitude, or shape between con-
trol and MAP1B/ neurons (supplemental Fig. 2, A–C).
We also analyzed the postsynaptic properties of control and
MAP1B/ neurons (Fig. 5A), recording miniature synaptic
currents mediated by AMPA receptors under voltage-clamp at
60 mV in the presence of a selective NMDA receptor antag-
onist (2-amino-5-phosphonovaleric acid) and tetrodotoxin (to
prevent action potential firing). The amplitude of miniature
excitatory postsynaptic currents (mEPSC) recorded in knock-
out neurons was significantly smaller than that of control neu-
rons (Fig. 5), an effect that was observed throughout the whole
distribution of mEPSC amplitudes (see the left-shift in the
cumulative distribution; Fig. 5B). This effect suggests a decrease
in the number of functional AMPA receptors at synapses in
knock-out neurons, in line with the relative predominance of
immature dendritic spines in these neurons.
MAP1B-deficient Mice Exhibit Weaker Postsynaptic Rac1
Activity and Stronger RhoA Activity—Given the observed mor-
phological andmorphometric abnormalities in dendritic spines
of MAP1B-deficient neurons, we investigated the function of
RhoGTPases in these neurons. Active Rac1 and RhoA were
measured in the postsynaptic density fraction of adult WT and
MAP1B/ animals. We previously described decreases in
Rac1 and Cdc42 activity and increased RhoA activity in
MAP1B-deficient hippocampal neurons, resulting in impaired
axonal elongation in short term cell cultures (18). Moreover,
several previous studies have shownRho-GTPases to be impor-
tant regulators of the actin cytoskeleton that contributes to the
structural plasticity of excitatory synapses (26, 27). Specifically,
Rac1 and RhoA are keymolecules in the regulation and dynam-
ics of dendritic spines (26, 52–54).
Levels of MAP1B were first measured in Western blots of
extracts from wild type and heterozygous MAP1B/ mice.
Knock-out animal could not be used for these experiments as
the MAP1B/ mouse suffers early postnatal lethality. As
expected, there was less MAP1B in the MAP1B/ extracts
than in the wild type extracts (Fig. 6A).
To measure Rac1 activity, we performed a pulldown assay
using a GST fusion protein corresponding to the p21 binding
domain (residues 67–150) of murine PAK1, a Rac effector that
binds to Rac1-GTP with a high affinity but not to Rac1-GDP.
Rac1 activity was significantly lower in postsynaptic density
fraction extracts from MAP1B/ mice than in WT extracts,
whereas the total Rac1 protein was similar in both (Fig. 6B).
Quantitative analyses revealed a 40% decrease in Rac1 activity
in MAP1B/ versus control samples (Fig. 6B, right panel). By
contrast, RhoA activity was stronger in MAP1B/ than WT
extracts, and a 45% increase in RhoA activation in MAP1B/
extracts over the activity in theWT sample was quantified (Fig.
6C, right panel). This increase was not due to enhanced RhoA
expression, as the overall levels of RhoA were comparable in
both WT and MAP1B/mice (Fig. 6C).
We also investigated whether the activity of downstream
effectors of Rac1 signaling, such as cofilin, was altered in
MAP1B/ animals. Cofilin protein binds to F-actin and con-
trols the turnover of the subunits in the polymer, increasing
FIGURE 4. Three-dimensional reconstruction of dendritic spines in 21 DIV hippocampal neurons. A–D, deconvolved confocal images are shown of
MAP1B/ (A) andMAP1B/neurons (B), created using theHuygens programand reconstructedwith the IDL timeCalc program. Scale bar 5m.Note that
dendrites from wild type neurons have different types of spines, including mushroom, stubby, and branched, constituting the population of mature spines
(arrows in C). By contrast, knock-out neurons predominantly generate long protrusions without a distinguishable head (arrows in D). Scale bar 2 m. E, a
graph shows thepercentageof thedifferent types of spines found in dendrites ofMAP1B/ andMAP1B/neurons (n 10neurons from three independent
experiments per condition).
Role of MAP1B in Dendritic Spine Development
NOVEMBER 25, 2011•VOLUME 286•NUMBER 47 JOURNAL OF BIOLOGICAL CHEMISTRY 40643
 at CTRO
 BIO
LO
G
IA M
O
LECULAR, on O
ctober 2, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
depolymerization at the end of the filament and severing long
actin filaments. Cofilin is rendered inactive when it is phospho-
rylated by the protein kinase LIMK-1 (55), increasing the den-
sity andmodifying themorphology of dendritic spines (56).We
quantified the amount of phosphorylated cofilin and total cofi-
lin in the post-synaptic fractions from MAP1B/ and
MAP1B/ animals. Although no differences in the levels of
total cofilin were detected, therewas less phospho-cofilin in the
MAP1B/ extracts (Fig. 6D), consistent with the increase in
the number of immature dendritic spines found in MAP1B/
neurons.
MAP1B may increase and decrease Rac1 and RhoA activity,
respectively, by binding to a GEF that acts on Rac1 or RhoA
proteins. Tiam1 is a Rac1GEF (57) that co-immunoprecipitates
with MAP1B in extracts of young mice brains (18). Indeed,
Tiam1 and MAP1B were co-immunoprecipitated from hip-
pocampal extracts of adult mice (Fig. 7, A and B).
To explain how the absence of MAP1B could increase RhoA
activity in the adult brain, we analyzedMAP1B binding toGEF-
H1, which acts on RhoA. GEF-H1 was recently proposed to
form a complex with the RhoA protein and MTs (58). Now we
have detected that GEF-H1 co-immunoprecipitates with
MAP1B in the adult brain (Fig. 7, A and B).
To determine whether MAP1B simply immunoprecipitates
with tubulin-binding proteins such as GEF-H1 or Tiam1
through its interaction with tubulin polymers, we performed
further immunoprecipitation studies using Tau protein,
another MAP present in mature neurons that localizes in den-
dritic compartments (59). Significantly, the Tau protein did not
co-immunoprecipitate with either Tiam1 or GEF-H1 (Fig. 7, A
and B).
Similarly, to rule out the possibility that tubulin polymers
mediate the co-immunoprecipitation of GEFs withMAP1B, we
repeated the immunoprecipitations using cultured neurons
pretreated with the MT depolymerizing agent nocodazole.
After nocodazole treatment, Tiam1 andGEF-H1 still co-immu-
noprecipitated with MAP1B (Fig. 7C). However, mature neu-
rons contain a large population of stable MTs resistant to
nocodazole and with half-lives exceeding several hours (60).
Thus, we repeated these immunoprecipitation studies in a neu-
roblastoma cell line, N1E-115, pretreated with nocodazole.
This approach resulted in complete depolymerization of MTs
by nocodazole, yet MAP1B still co-immunoprecipitated with
the GEFs of interest (Fig. 7D). Based on these findings, we pro-
pose that MAP1B regulates Rac1 and RhoA activities through
interactions with GEFs.
FIGURE 5.Recordings ofminiature synaptic currents fromwild type andMAP1B/hippocampal neurons. Spontaneous eventswere recorded in 21DIV
neurons from MAP1B/ and MAP1B/ mice in patch-clamped conditions at 60 mV in the presence of 2-amino-5-phosphonovaleric acid (100 M) and
tetrodotoxin (1 M). A, representative traces from0.1 s of recordings from 21 DIV neurons from MAP1B/ and MAP1B/mice are shown. B, cumulative
distribution ofmEPSC amplitude recorded fromwild type (n 10374minis from 22 cells) andMAP1B/ (n 5304minis from 25 cells) hippocampal neurons
(*, p  0.0001, Kolmogorov-Smirnov test) are shown. C, average mEPSC amplitude recorded from MAP1B/ (22 neurons) and MAP1B/ (25 neurons)
hippocampal neurons are shown (*, p 0.01, Mann-Whitney test).
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DISCUSSION
MAP1B is predominantly expressed during neuronal devel-
opment, although strong expression is maintained in adult
brain regions that exhibit a high degree of plasticity (8, 61, 62).
At the subcellular level, MAP1B is mainly present in dendrites
of adult neurons (63) where it may contribute to AMPA recep-
tor trafficking through binding to glutamate receptor interact-
ing protein 1 (GRIP) (64, 65). MAP1B has also been detected in
postsynaptic densities (23), and it was demonstrated to be a
synaptic protein in a proteomic analysis (21, 22). Here, we dem-
onstrate the presence ofMAP1B in the adult hippocampus and
in mature neurons in culture. In the brain, MAP1B is more
abundant in the gray matter, and it is enriched in somatoden-
dritic compartments. Moreover, confocal microscopy revealed
the presence of MAP1B in a small percentage of dendritic
spines in long-term neuronal cultures.
Dendritic spines are small protrusions whose main cytoskel-
etal component is actin. Indeed, MTs were assumed to be
absent from dendritic spines until the transient entry of
dynamicMTs into dendritic spines was recently described (32–
34). MAP1B is an MT-associated protein that is implicated in
the maintenance of dynamic MT populations (66, 67), and it
interacts directly with actin (37, 38). Thus, it is reasonable to
hypothesize that MAP1B can enter into dendritic spines in
association with either dynamic MTs or actin microfilaments.
The movement of MAP1B into dendritic spines appears to be
transient based on the small number ofMAP1B-positive spines
detected. This observation is in agreement with the percentage
of MTs detected in dendritic protrusions (1% of dendritic
protrusions) (33). Therefore, we propose that MAP1B gains
access to dendritic spines by accompanying dynamic MTs.
Interestingly, a large number of spines have previously found to
contain MTs, although the duration for which the MTs
remained in each spine is limited to a few minutes (33). This
could explain why, although we only detect MAP1B in a small
percentage of dendritic spines at a fixed time, the effect seems
to be global on all spines. A possible role for dynamic MTs in
dendritic spines is supported by the decrease in mature den-
dritic spines seen in neurons lacking the EB3 protein (32, 34).
Moreover, low concentrations of nocodazole suppress the syn-
aptic potentiation induced in response to high frequency stim-
ulation (34). These effects may involve the local regulation of
MT dynamics. Interestingly, MAP1B increases the amount of
tyrosinated (i.e. more dynamic) MTs through a mechanism
involving the interaction of MAP1B with the enzyme tubulin
tyrosine ligase (67). It has been proposed that the transient
entry of MTs into dendritic spines serves as a signal to locally
reorganize the actin cytoskeleton and regulate spine size (33,
34). The postsynaptic accumulation of MAP1B suggests a role
in the activity of the synapse, spine formation, and synapse
establishment. In agreement, we found that the density of den-
dritic protrusion decreases in neurons fromMAP1B knock-out
mice, and the number of filopodia-like protrusions increases
when compared with wild type neurons. Finally, the immature
phenotype of dendritic protrusions in mature MAP1B-defi-
cient neuronswas associatedwith a reduction inmEPSC ampli-
tude. These findings demonstrate the importance ofMAP1B in
dendritic spine formation and synaptic maturation.
Actin cytoskeleton plays an important role in dendritic spine
morphogenesis and dynamics (68–70). Numerous actin-bind-
FIGURE 6.MAP1B-deficient mice exhibit weaker synaptosome Rac1 activity and stronger RhoA activity. A, a Western blot demonstrates higher MAP1B
levels in the adult hippocampus of WT (/) mice (upper panel) than in MAP1B/ animals. -Tubulin was used as loading control. Quantitative analysis
confirmed a significant decrease inMAP1B in heterozygousMAP1B/ extracts (*, p 0.01, Student’s t-test). B, a Western blot shows lower Rac1-GTP levels in
synaptosome extracts from the adult brain of heterozygous MAP1B/ animals versus those of the WT (/) mice. Total Rac1 was used as a loading control.
Quantitative analysis confirmed the significant decrease in Rac1 activity in heterozygousMAP1B/extracts (*,p0.05, Student’s t test).C , shown is increased
RhoA activity in synaptosome fractions from MAP1B/ versus control samples. Total RhoA was used as a loading control. Quantitative analysis indicated a
significant increase in RhoA activity in heterozygous (/) fractions (*, p  0.05, Student’s t test). D, shown are total cofilin and phosphocofilin levels in
synaptosome extracts obtained from the adult brain of heterozygous MAP1B/ and WT (/) mice, as detected by Western blot. Phosphocofilin levels
decreased inheterozygousMAP1BanimalswhencomparedwithWTcontrols (right panel; *,p0.05,Mann-Whitney test). Cofilinwasusedas a loading control.
n 4 animals per genotype in A–D.
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ing proteins under the control of different pathways, such as
Rho-GTPases, regulate actin filament dynamics. MAP1B was
recently reported to modulate Rac1-GTPase activity by inter-
acting with Tiam1, a Rac1-GEF. MAP1B-deficient neurons
exhibit less Rac1 and cdc42 activity, whereas RhoA activity is
increased (18). Here we demonstrate that this alteration is
maintained in the adult brain of MAP1B heterozygous mice
(MAP1B/), specifically in postsynaptic synaptosome frac-
tions. These animals exhibited decreased Rac1 activity and
increased levels of RhoA-GTP. Several findings implicate Rac1
and RhoA in both the formation and maturation of spines. In
support of our findings, previous studies reported that a domi-
nant-negative Rac1 causes a reduction in pyramidal neuron
spine density in hippocampal slices (26, 52, 54). Neurons
expressing this dominant-negative construct have significantly
longer dendritic spines than those of controls. Furthermore,
Rac1 inhibition reduces spine head growth. Similarly, inhibi-
tion of Rac1 function impairs AMPA receptor clustering at syn-
apses and reduces mEPSC amplitude (71). These observations
demonstrate a role for Rac1 in spine maintenance and matura-
tion, possibly via its modulation of the actin cytoskeleton (72).
In contrast to Rac1, RhoA inhibits spine formation and matu-
ration (53), and thus, it may be inactivated during synaptogen-
esis. Introduction of constitutive-active RhoA decreases spine
density, demonstrating the negative effect of RhoA on spine
formation and maintenance (26, 52, 54). Conversely, RhoA
inhibition increases the density of spines in cortical and hip-
pocampal mouse neurons (26).
Interactions (direct or indirect) betweenMAP1B and Tiam1
have already been described (18). In agreement, we found that
MAP1B co-immunoprecipitates with Tiam1 in the adult brain.
Moreover, we found thatMAP1B co-immunoprecipitated with
another specific RhoA-GEF, GEF-H1, and that these interac-
tions occurred independently of the presence of tubulin poly-
mers. Interestingly, both Tiam1 and GEF-H1 have been
reported to be active in dendritic spines. Tiam1 has been linked
to NMDA receptor activity in the development of dendritic
arbors and spines, and knockdown of Tiam1 by RNAi in hip-
pocampal neurons leads to a reduction in spine density (28).
The RhoA-specific GEF-H1 is an AMPA receptor-interacting
protein (73) that translocates into dendritic spines (74). Inhibi-
tion ofAMPAreceptor activity promotes the activation ofGEF-
H1, which in turn negatively regulates spine development by
the activation of the RhoA cascade (73). This GEF has been
proposed to mediate the cross-talk betweenMTs and the actin
cytoskeleton (58). RNAi-mediated knockdown of GEF-H1
increases spine density and length, perhaps due to Rac1 inhibi-
tion by RhoA (75). Thus, displacing the equilibrium between
RhoA activation and inactivation may alter dendritic spine
morphology, which could occur if MAP1B loss-of-function is
paralleled by an increase in GEF-H1 activity.
The importance of proteins that regulate the actin cytoskel-
eton is clear, and they are in turn regulated by Rho GTPases
during dendritic spine development.Wedemonstrated that the
activity of proteins involved in regulating the morphology of
dendritic spines, such as cofilin, is altered in the absence of
FIGURE7.MAP1Bco-immunoprecipitateswith theGEFsTiam1andGEF-H1 irrespectiveof thepresenceorabsenceof tubulinpolymers.AandB, shown
is co-immunoprecipitation (IP) of MAP1B with Tiam1, the specific Rac1 GEF, and with GEF-H1, the specific RhoA GEF, in Western blots (WB) (A). Immunopre-
cipitationof Tauproteinwasperformed inparallel to assess its co-immunoprecipitationwith either Tiam1orGEF-H1 (A). Positive controls showMAP1BandTau
immunoprecipitations after theadditionof the respective antibodies (B).C, hippocampalneuronswerepretreatedwithnocodazole (30m) for 3h, andMAP1B
was immunoprecipitated, showing that Tiam1 and GEF-H1 could be detected in the immunoprecipitate. D, detection of Tiam1 and GEF-H1 after MAP1B
immunoprecipitation in N1E-115 neuroblastoma cells pretreatedwith 10mnocodazole for 20min is shown. Negative controls, performed in the absence of
specific antibodies (see “Experimental Procedures”) are shown in the different panels (control). Co-immunoprecipitation of GEFs with MAP1B occurred
irrespective of the presence of tubulin polymers.
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MAP1B. Cofilin is found at the postsynaptic density (76), where
it induces the dynamic disassembly of actin filaments that is
required tomaintain the length and propermorphology of den-
dritic spines (77, 78). The decrease in phosphocofilin levels
observed in synaptosome fractions from heterozygous mice
correlates with a decrease in Rac1 activity. LIM domain kinase
(LIMK) is a common downstream effector of Rho family small
GTPases (79–81) that phosphorylates and inactivates cofilin
(55). LIMK-1 knock-out mice exhibit decreased levels of phos-
phorylated cofilin (82). Interestingly, spine morphology is also
altered in these mice; the spines developing a long neck and
small head, similar to those described in the present study.
Moreover, the amount of phosphorylated ADF/cofilin was
markedly diminished, whereas the total ADF/cofilin remained
similar to that observed in wild type neurons (82).
In summary, the present findings support a novel function
forMAP1B in controlling dendritic spinemorphology and syn-
aptic function via the regulation of actin cytoskeleton through
Rac1 and RhoA activity. MAP1B may contribute to the spatio-
temporal activation of these Rho-GTPases in dendritic spines
by binding to the Rac1 and RhoA GEFs, Tiam1, and GEF-H1.
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